Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-25-000020
Filing Date
2025-05-01
Accepted
2025-04-30 18:03:49
Documents
109
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bhc-20250331.htm   iXBRL 10-Q 2075542
2 EX-10.2 exhibit102q12025.htm EX-10.2 176657
3 EX-31.1 exhibit311q12025.htm EX-31.1 10086
4 EX-31.2 exhibit312q12025.htm EX-31.2 10133
5 EX-32.1 exhibit321q12025.htm EX-32.1 6569
6 EX-32.2 exhibit322q12025.htm EX-32.2 6502
  Complete submission text file 0000885590-25-000020.txt   11782233

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhc-20250331.xsd EX-101.SCH 87210
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhc-20250331_cal.xml EX-101.CAL 89326
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhc-20250331_def.xml EX-101.DEF 491411
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhc-20250331_lab.xml EX-101.LAB 894373
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhc-20250331_pre.xml EX-101.PRE 711385
111 EXTRACTED XBRL INSTANCE DOCUMENT bhc-20250331_htm.xml XML 1878119
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 25898225
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)